Key Market Segments
By Product
-
Monoclonal Antibodies
-
Insulin
-
Fusion Protein
-
Erythropoietin
-
Interferon
-
Human Growth Hormone
-
Follicle Stimulating Hormone
By Applications
-
Metabolic Disorders
-
Immunologic Disorders
-
Hematological Disorders
-
Cancer
-
Hormonal Disorders
-
Genetic Disorders
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Turkey
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g., Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: Advancements in drug delivery, like sustained-release injectables, transdermal systems, and inhalable proteins, are improving patient compliance and therapeutic efficiency. These innovations are expanding the usability of protein therapeutics in chronic and long-term disease management.
Ans: Key trends include the rise of biosimilars, AI-driven protein design, growth in antibody-drug conjugates (ADCs), and increasing investments in personalized medicine. Regulatory support for faster approvals is also enabling quicker entry of novel protein-based therapies.
Ans: The rising demand for monoclonal antibodies is significantly boosting the protein therapeutics market, driven by their targeted action, reduced side effects, and success in treating cancer, autoimmune, and infectious diseases.
Ans: Key players include Bayer AG, Bristol-Myers Squibb, Daiichi Sankyo Company, Abbott, Sanofi, Thermo Fisher Scientific Inc., Genzyme Corporation, AbbVie Inc., Leadiant Biosciences, and Takeda Pharmaceutical Company Limited.
Ans: The Protein Therapeutics market size was valued at USD 375.32 billion in 2024 and is projected to reach USD 645.61 billion by 2032, growing at a CAGR of 7.03% from 2025 to 2032.